Brief: Channel Therapeutics Announces Reverse Stock Split as Merger with Pelthos Closes and $50.1M Private Placement Completes
27/06/2025 14:17
June 27 (Reuters) - Channel Therapeutics Corp CHRO.A: CHANNEL THERAPEUTICS ANNOUNCES REVERSE COMMON STOCK SPLIT IN CONJUNCTION WITH THE CLOSE OF THE MERGER WITH PELTHOS THERAPEUTICS AND CONCURRENT $50.1 MILLION PRIVATE PLACEMENT CHANNEL THERAPEUTICS CORP - ANNOUNCES 10-FOR-ONE REVERSE STOCK SPLIT Source text: ID:nGNXbzzwxT Further company coverage: CHRO.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pelthos Therapeutics
See all newsPelthos Therapeutics falls as co says will restate Q1 financial statements
Brief: Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
Pelthos Therapeutics Q2 revenue rises on Zelsuvmi adoption
Brief: Pelthos Therapeutics Announces CFO Transition
Brief: Pelthos Therapeutics Announces First Patient Dosed In Phase 1B/2A Clinical Trial Of Ct2000 In Eye Pain